Literature DB >> 8105168

Control of cerebral oedema by total hepatectomy and extracorporeal liver support in fulminant hepatic failure.

J Rozga1, L Podesta, E LePage, A Hoffman, E Morsiani, L Sher, G M Woolf, L Makowka, A A Demetriou.   

Abstract

Keeping a patient with fulminant hepatic failure (FHF) alive until a donor liver is available for transplantation can be a problem. We describe an 18-year-old woman with paracetamol-induced FHF, who was treated by total hepatectomy, hypothermia, plasma exchange, and extracorporeal liver support. The patient was anhepatic for 14 h. The liver-support system consisted of plasma separation and perfusion through a charcoal filter and a hollow-fibre module seeded with matrix-attached porcine hepatocytes. With artificial liver treatment there was reversal of severe neurological dysfunction, normalisation of intracranial pressure, and decreased serum ammonia. The patient underwent emergency transplantation with an ABO-incompatible liver, followed by transplantation with a compatible organ eight days later. The patient has fully recovered and is neurologically intact.

Entities:  

Mesh:

Year:  1993        PMID: 8105168     DOI: 10.1016/0140-6736(93)91947-k

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  19 in total

Review 1.  Animal models of acute hepatic failure.

Authors:  T M Rahman; H J Hodgson
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

2.  Liver transplantation and artificial liver support in fulminant hepatic failure.

Authors:  X F Zhu; G H Chen; X S He; M Q Lu; G D Wang; C J Cai; Y Yang; J F Huang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

3.  The effects of moderate hypothermia on energy metabolism and serum inflammatory markers during laparotomy.

Authors:  Paisarn Vejchapipat; Sopee Poomsawat; Yong Poovorawan; Edward Proctor; Agostino Pierro
Journal:  Pediatr Surg Int       Date:  2006-01       Impact factor: 1.827

4.  Artificial and bioartificial liver support.

Authors:  Gesine Pless
Journal:  Organogenesis       Date:  2007-01       Impact factor: 2.500

5.  Telomerase activity and hepatic functions of rat embryonic liver progenitor cell in nanoscaffold-coated model bioreactor.

Authors:  Shibashish Giri; Karen Nieber; Ali Acikgöz; Sanja Pavlica; Mario Keller; Augustinus Bader
Journal:  Mol Cell Biochem       Date:  2009-10-09       Impact factor: 3.396

6.  A bioartificial liver to treat severe acute liver failure.

Authors:  J Rozga; L Podesta; E LePage; E Morsiani; A D Moscioni; A Hoffman; L Sher; F Villamil; G Woolf; M McGrath
Journal:  Ann Surg       Date:  1994-05       Impact factor: 12.969

Review 7.  Renal dysfunction associated with liver transplantation.

Authors:  R M Jindal; I Popescu
Journal:  Postgrad Med J       Date:  1995-09       Impact factor: 2.401

Review 8.  New concepts in the mechanism of ammonia-induced astrocyte swelling.

Authors:  M D Norenberg; A R Jayakumar; K V Rama Rao; K S Panickar
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

Review 9.  Acute liver failure.

Authors:  Ludwig Kramer
Journal:  Wien Klin Wochenschr       Date:  2004-02-16       Impact factor: 1.704

10.  Brain cytokine flux in acute liver failure and its relationship with intracranial hypertension.

Authors:  Gavin Wright; Debbie Shawcross; Steven W M Olde Damink; Rajiv Jalan
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.